Why should you add Blonder Tongue Laboratories, Inc. (BDR) to your portfolio?

Blonder Tongue Laboratories, Inc. (NYSE:BDR) has a beta value of 0.33 and has seen 2,223,795 shares traded in the last trading session. The company, currently valued at $19.68 Million, closed the last trade at $1.7 per share which meant it lost -$0.02 on the day or -1.16% during that session. The BDR stock price is -123.53% off its 52-week high price of $3.8 and 77.65% above the 52-week low of $0.38. If we look at the company’s 10-day average daily trading volume, we find that it stood at 1.9 Million shares traded. The 3-month trading volume is 916.82 Million shares.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

The consensus among analysts is that Blonder Tongue Laboratories, Inc. (BDR) is a 0 stock at the moment, with a recommendation rating of 0. None of the analysts rate the stock as a Sell, while none rate it as Overweight. None out of 0 have rated it as a Hold, with no one of them advising it as a Buy. None have rated the stock as Underweight. The expected earnings per share for the stock is $0.

Despite being -1.16% in the red in last session, the stock has traded in the green over the last five days, with the highest price hit on Monday, Feb 01 when the BDR stock price touched $2.33 or saw a rise of 27.04%. Year-to-date, Blonder Tongue Laboratories, Inc. shares have moved 27.82%, while the 5-day performance has seen it change 18.88%. Over the past 30 days, the shares of Blonder Tongue Laboratories, Inc. (NYSE:BDR) have changed 25.93%. Short interest in the company has seen 140.29 Million shares shorted with days to cover at 0.15.

Blonder Tongue Laboratories, Inc. (BDR) estimates and forecasts

If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was +11.8% over the past 5 years. Earnings growth for 2021 is a modest +48.6%.

Blonder Tongue Laboratories, Inc. (NYSE:BDR)’s Major holders

Insiders own 62.77% of the company shares, while shares held by institutions stand at 18% with a share float percentage of 48.33%. Investors are also buoyed by the number of investors in a company, with Blonder Tongue Laboratories, Inc. having a total of 10 institutions that hold shares in the company. The top two institutional holders are Bridgeway Capital Management, Inc. with over 310.1 Thousand shares worth more than $254.31 Thousand. As of September 29, 2020, Bridgeway Capital Management, Inc. held 2.68% of shares outstanding.

The other major institutional holder is Renaissance Technologies, LLC, with the holding of over 108.42 Thousand shares as of September 29, 2020. The firm’s total holdings are worth over $88.91 Thousand and represent 0.94% of shares outstanding.

Get the hottest stocks to trade every day before the market opens 100% free. Click here now.

Also the top two Mutual Funds that are holding company’s shares are Bridgeway Funds Inc-Ultra Small Company Fund and Bridgeway Funds Inc-Ultra Small Company Market Fund. As of September 29, 2020, the former fund manager holds about 2.51% shares in the company for having 290100 shares of worth $237.91 Thousand while later fund manager owns 20Thousand shares of worth $16.4 Thousand as of September 29, 2020, which makes it owner of about 0.17% of company’s outstanding stock.


A Backdoor Way To Profit From Today’s Crypto Bull Market

Even if you’re not actively in crypto, you deserve to know what’s actually going on…

Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.

Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.

Sponsored


Latest posts